Alpex Acquisition Corporation (ALPX)
NASDAQ: ALPX · Real-Time Price · USD
10.00
0.00 (0.00%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Company Description
Alpex Acquisition Corporation focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
The company was incorporated in 2026 and is based in Wilmington, Delaware.
Alpex Acquisition Corporation
| Country | United States |
| Founded | 2026 |
| IPO Date | Jun 25, 2026 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Xiaolin Zheng |
Contact Details
Address: 300 Delaware Ave., Suite 210 #494 Wilmington, Delaware 19801 United States | |
| Phone | 302 251 6637 |
Stock Details
| Ticker Symbol | ALPX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0002125551 |
| Employer ID | 86-3959763 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Daniel R Vlock, MD | President, Chief Executive Officer and Director |
| Thomas T. Thomas | Chief Financial Officer |
| Gerald B. Pier, PhD | Chief Scientific Officer |
| William W. Chin, MD | Senior Strategic Advisor, Director |
| Christine de los Reyes, PharmD, MBA | Chief Business Officer, Chief Commercialization Officer |
| Peter J. Werth | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 25, 2026 | 424B4 | Prospectus |
| Jun 24, 2026 | EFFECT | Notice of Effectiveness |
| Jun 24, 2026 | CERT | Certification by an exchange approving securities for listing |
| Jun 24, 2026 | 8-A12B | Registration of securities |
| Jun 5, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| May 22, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Apr 10, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |